Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wellgistics Health (WGRX) Shares Outstanding (Weighted Average) (2023 - 2025)

Wellgistics Health filings provide 3 years of Shares Outstanding (Weighted Average) readings, the most recent being $71.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 50.23% to $71.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $71.0 million, a 50.23% increase, with the full-year FY2025 number at $71.0 million, up 50.23% from a year prior.
  • Shares Outstanding (Weighted Average) hit $71.0 million in Q4 2025 for Wellgistics Health, down from $74.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $74.4 million in Q3 2025 to a low of $44.7 million in Q4 2023.
  • Median Shares Outstanding (Weighted Average) over the past 3 years was $48.4 million (2024), compared with a mean of $54.4 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 5.66% in 2024 and later surged 53.66% in 2025.
  • Wellgistics Health's Shares Outstanding (Weighted Average) stood at $44.7 million in 2023, then rose by 5.66% to $47.3 million in 2024, then surged by 50.23% to $71.0 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $71.0 million (Q4 2025), $74.4 million (Q3 2025), and $61.8 million (Q2 2025) per Business Quant data.